About the ANCA-Associated Vasculitis Working Group

The methods for creating a composite outcome are different than for individual domain-directed outcomes and this Workshop will help attendees understand the steps required for this process through a project that is funded by ACR and EULAR to create response criteria for ANCA-associated vasculitis for use in clinical trials. Attendees are encouraged before the Workshop to view the short but highly informative videos developed to inform everyone on the disease under study and the methods employed for this project.

Haner_Direskeneli

Haner Direskeneli

Co-Chair

sarah mackie

Sarah Mackie

Co-Chair

Peter Merkel

Peter Merkel

Co-Chair

gunnar

Gunnar Tómasson

Co-Chair

kaitlin quinn

Kaitlin Quinn

Fellow

Screen Shot 2021-02-17 at 11.40.13 AM

Sara Monti

Fellow

georgia lanier

Georgia Lanier

Patient Research Partner

Vasculitis Overview

OMERACT Endorsed Core Domain Set for Clinical Trials in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Screenshot 2025-01-06 at 1.39.37 PM
Scroll to Top